.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Cipla
AstraZeneca
Daiichi Sankyo
Moodys
Queensland Health
Accenture
Novartis
US Department of Justice
Federal Trade Commission

Generated: June 28, 2017

DrugPatentWatch Database Preview

NEODECADRON Drug Profile

« Back to Dashboard

What is the patent landscape for Neodecadron, and when can generic versions of Neodecadron launch?

Neodecadron is a drug marketed by Merck and is included in two NDAs.

The generic ingredient in NEODECADRON is dexamethasone sodium phosphate; neomycin sulfate. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone sodium phosphate; neomycin sulfate profile page.

Summary for Tradename: NEODECADRON

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list22
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NEODECADRON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
NEODECADRON
dexamethasone sodium phosphate; neomycin sulfate
SOLUTION/DROPS;OPHTHALMIC050322-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Merck
NEODECADRON
dexamethasone sodium phosphate; neomycin sulfate
OINTMENT;OPHTHALMIC050324-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Daiichi Sankyo
Moodys
Federal Trade Commission
US Department of Justice
Merck
AstraZeneca
Boehringer Ingelheim
McKinsey
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot